Table 1.
Baseline Characteristics
| Routine specialty care (n = 14) |
RGM intervention (n = 14) |
|
|---|---|---|
| Age, years (SD) | 52 (14) | 54 (16) |
| Female, n (%) | 3 (21) | 5 (36) |
| White, n (%) | 8 (57) | 8 (57) |
| Hispanic, n (%) | 1 (7) | 3 (21) |
| Self-reported DM duration, years (SD) | 8 (11) | 12 (8) |
| Length of stay, days (SD) | 4.0 (2) | 4.9 (3) |
| Admission diagnosis, n (%) | ||
| Cardiovascular disease | 3 (21) | 3 (21) |
| DM | 5 (36) | 2 (14) |
| Pancreatitis | 1 (7) | 1 (7) |
| Surgery | 4 (29) | 4 (29) |
| Comorbidities, n (%) | ||
| Cardiovascular disease | 4 (29) | 3 (21) |
| Hypertension | 7 (50) | 10 (71) |
| Chronic kidney diseasea | 0 (0) | 4 (29) |
| Depression | 3 (21) | 1 (7) |
| Asthma/COPD | 3 (21) | 3 (21) |
| Baseline HbA1c, % (SD) | 10.2 (2.4) | 10.5 (1.9) |
| Baseline glycated albumin, % (SD)b | 30 (10) | 26 (7) |
| Insulin-naïve prior to admission, n (%) | 8 (57) | 4 (29) |
| Glucocorticoids at discharge, n (%) | 1 (7) | 2 (14) |
| Time to postdischarge follow-up, days (SD) | 30 (5) | 34 (11) |
| Baseline PAID score (SD) | 29 (15) | 26 (19) |
Abbreviations: COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; HbA1c = hemoglobin A1c; PAID = Problem Areas in Diabetes Scale [0–100]; RGM = remote glucose monitoring.
a
P = .01.
b
Reference range for glycated albumin enzyme-linked immunosorbent assay, 11–16%.